Sunday, August 08, 2004 3:12:01 PM
From the Affymetrix website:
Mapping 100K Set
The GeneChip® Mapping 100K Set is the first in a family of products for whole-genome association studies. It is comprised of a set of two arrays that enable genotyping of greater than 100,000 SNPs with a single primer. The high throughput and ease of use of the Mapping 100K Set at a cost of one cent per SNP enable you to conduct whole-genome association studies at your benchtop for the first time. It will provide you with better results for applications, including cancer genetics, linkage disequilibrium, case-control, family-based association studies, chromosomal copy number change analysis, and population genetics.
Benefits of the Mapping 100K Set include:
• Enabling Technology - The Mapping 100K Set is easy to use and offers genotypes at a cost of less than one cent per SNP. This enables you to begin experiments you have always wanted to do.
• Proven Assay - The Mapping 100K Set uses the GeneChip® Mapping Assay, which has been validated in over 15 published studies.
• Small Sample Requirement - The Mapping 100K Set only requires 250 ng DNA per array.
• Scalability - You can generate 3.2 million genotypes per day with a standard configuration of four fluidics stations. You can generate higher throughput by adding instruments.
• Vision - The Mapping 100K Set is the first in a family of products towards a goal of 500,000 SNPs.
-----
With DNAP's research connections with Moffitt and indirectly with IBM and Affymetrix, the future for DNAP is getting really exciting...
JMHO of course!
Robert
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM